Skip to main content
Home ViewHub

Main Menu

  • About
  • Vaccine Data Explorer
    • COVID Vaccines
    • Haemophilus Influenzae Type B Vaccine
    • Human Papillomavirus Vaccine
    • Inactivated Polio Vaccine
    • Measles-Rubella Vaccine
    • Measles-containing-vaccine second-dose
    • Pneumococcal Conjugate Vaccine
    • Rotavirus Vaccine
    • Typhoid Conjugate Vaccine
  • Resources
  • Country Pages
  • Topic Pages
COVID Vaccines (COVID) Haemophilus Influenzae Type B Vaccine (Hib) Human Papillomavirus Vaccine (HPV) Inactivated Polio Vaccine (IPV) Measles-containing-vaccine second-dose (MCV2) Measles-Rubella Vaccine (MR) Pneumococcal Conjugate Vaccine (PCV) Rotavirus Vaccine (Rota) Typhoid Conjugate Vaccine (Typhoid)
Introduction & Use Access & Coverage Data Download Impact Studies Product Characteristics Resources
Explore other pages for this Antigen
  • January 2023 VIEW-hub Report on Global Vaccine Introduction and Implementation
    Feb 22, 2023
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • October 2022 VIEW-hub Report on Global Vaccine Introduction and Implementation
    Nov 1, 2022
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • July 2022 VIEW-hub Report in Global Vaccine Introduction and Implementation
    Aug 2, 2022
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • March 2022 VIEW-hub Report in Global Vaccine Introduction and Implementation
    Apr 18, 2022
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • September 2021 VIEW-hub Report in Global Vaccine Introduction and Implementation
    Oct 29, 2021
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • June 2021: VIEW-hub Report
    Aug 2, 2021
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • March 2021 VIEW-hub Report on Global Vaccine Introduction and Implementation
    May 7, 2021
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

  • December 2020 VIEW-hub Report: Global Vaccine Introduction and Implementation
    Feb 8, 2021
    VIEW-Hub Reports

    The VIEW-hub report displays data and figures on the introduction, use, and coverage status of human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the 73 Gavi countries

  • Current and Upcoming Rotavirus Vaccines
    Sep 28, 2020
    Other

    This brief gives an outline of the current rotavirus products and upcoming products.

  • The Impact of Rotavirus Vaccination
    Sep 28, 2020
    Other

    This brief outlines the impact of rotavirus vaccination on rotavirus and diarrhea-related hospitalizations and deaths.

Pagination

  • 1
  • 2
  • Next
  • Last

Explore more data and content

Introduction & Use
Access & Coverage
Data Download
Impact Studies
Product Characteristics

ViewHub Logo

A project of:

Citation

International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub. www.view-hub.org. Accessed: .

Contact

Contact Us

If you have any questions or comments, or would like to notify us of any technical issues you are experiencing with VIEW-hub, please get in touch. We welcome and appreciate your valuable feedback.

Built by Graphicacy